Page last updated: 2024-10-26

edrophonium and Brain Stem Neoplasms, Primary

edrophonium has been researched along with Brain Stem Neoplasms, Primary in 1 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, K1
Baba, S1
Iwasaki, Y1

Other Studies

1 other study available for edrophonium and Brain Stem Neoplasms, Primary

ArticleYear
Pseudomyasthenia in a patient with pontine glioma.
    Clinical neurology and neurosurgery, 2006, Volume: 108, Issue:8

    Topics: Astrocytoma; Brain Stem Neoplasms; Cranial Nerve Neoplasms; Cranial Nerves; Diagnosis, Differential;

2006